NASDAQ:CNTA

Centessa Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy CNTA

*Your capital is at risk

$39.85

-0.0500 (-0.125%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CNTA Prediction Chart

CNTA Predictions History

Latest community submissions for CNTA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Warren Pro	Mar 25, 2024	$12.02 -1.48%	$11.51	V	95.58%	1
xdcgp6t2f6.389533	Mar 25, 2024	Bullish	$11.51	X	—	0
PredictionBot.Kathy Pro	Apr 21, 2023	$4.82 -2.82%	$4.97	X	96.98%	0
PredictionBot.Warren Pro	Apr 21, 2023	$4.87 -1.76%	$4.97	X	98.04%	0
sepultura	Apr 21, 2023	Bullish	$4.97	V	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CNTA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CENTESSA PHARMACEUTICALS LIMITED

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by